🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
This is a two stage study, with an initial dose escalation phase I study an...
Status
Active Not Recruiting
Location
Velindre NHS Trust
Start Date
2014-05-07
Trial ID
NCT01992952
Treatments Being Tested
This is a Phase 1 dose-escalation study to evaluate the safety and tolerabi...
Status
Recruiting
Location
National University Hospital
Start Date
2018-12-03
Trial ID
NCT03772561
Treatments Being Tested
This study is a single arm, single center phase II study of AZD5363 in comb...
Status
Completed
Location
Samsung Medical Center
Start Date
2015-01-07
Trial ID
NCT02451956
Treatments Being Tested
This study is designed to determine the efficacy and safety of durvalumab i...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-12-21
Trial ID
NCT03742102
Treatments Being Tested
This phase Ib/II trial studies the side effects and best dose of olaparib a...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2014-11-11
Trial ID
NCT02208375
Treatments Being Tested
The purpose of this study is to measure the pharmacokinetics (PK), safety, ...
Status
Recruiting
Location
Research Site
Start Date
2026-01-06
Trial ID
NCT07343960
Treatments Being Tested
To find the highest tolerable dose of IACS-6274 that can be given alone, in...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-09-30
Trial ID
NCT05039801
Treatments Being Tested
This phase II study assesses the efficacy of the combination of olaparib wi...
Status
Terminated
Location
OHSU Knight Cancer Institute
Start Date
2018-12-12
Trial ID
NCT03801369
Treatments Being Tested
The trial consists of a series of parallel multi-centre single arm phase II...
Status
Completed
Location
Aberdeen Royal Infirmary
Start Date
2015-05-13
Trial ID
NCT02664935